NCT01401088

Evaluation of Safety and Efficacy of Glaucoma Shunt (Aurolab Artificial Drainage Implant) in Refractory Glaucoma

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: Aurolab · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of Aurolab Artificial Drainage Implant (AADI) on intraocular pressure reduction in patients with refractory glaucoma.

Detailed description

Aurolab Artificial Drainage Implant is a non resistant tube device based on Baerveldt implant. It reduces intra ocular pressure by draining aqueous from anterior chamber into sub-conjunctival space formed around base of the implant. Reduction of intraocular pressure prevents further damage to optic nerve and functional visual field loss in advanced refractory glaucoma.

Conditions

• Glaucoma

Interventions

Type	Name	Description
DEVICE	Artificial drainage implant	Artificial drainage implant is used for intra ocular pressure reduction in patient with refractory glaucoma

Timeline

• Start date: 2011-07-01
• Primary completion: 2013-11-01
• Completion: 2013-12-01
• First posted: 2011-07-25
• Last updated: 2013-01-03

Locations

1 site across 1 country: India